CAS 51-66-1
:N-(4-Méthoxyphényl)acétamide
- 4-(Acetylamino)anisole
- 4-Acetamidoanisole
- 4-Acetamidophenyl methyl ether
- 4-Methoxyanilino methyl ketone
- Acetamide, N-(4-methoxyphenyl)-
- Aceto-p-anisidide
- Acetyl-p-anisidine
- Metacetin
- Methacetin
- N-(4-Methoxyphenyl)acetamide
- N-(p-Methoxyphenyl)acetamide
- N-Acetyl-4-methoxyaniline
- N-Acetyl-p-anisidine
- N-Acetyl-p-methoxyaniline
- NSC 4687
- p-Acetanasidine~N-(Methoxyphenyl)acetamide
- p-Acetaniside
- p-Acetanisidide
- p-Acetanisidine
- p-Methoxyacetanilide
- Voir plus de synonymes
p-Acetanisidide
CAS :Formule :C9H11NO2Degré de pureté :>98.0%(HPLC)(N)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :165.19N-(4-Methoxyphenyl)acetamide
CAS :Formule :C9H11NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :165.18914'-Methoxyacetanilide
CAS :4'-MethoxyacetanilideFormule :C9H11NO2Degré de pureté :98%Couleur et forme : pale purple solidMasse moléculaire :165.19g/molMethacetin
CAS :Produit contrôléApplications Methacetin is evaluated in a breath test to predict early liver disfunction due to valproic acid and other cause. Methacetin breath test (MBT) is a rapid, non-invasive assessment of liver function in acute severe liver disease and a potential key tool in future dignosis.
References Dorloechter, L. et al.: Zeitsch. Ernaehrung., 36, 373 (1997); Holtmeier, J. et al.: Sand J. Gastroenterol., 41, 1336 (2006); Lalazar, G. et al.: World J. Gastroenterol., 15, 966 (2009);Formule :C9H11NO2Couleur et forme :NeatMasse moléculaire :165.19Methacetin
CAS :Methacetin is a chemical compound that is used in the diagnosis of liver impairment. It is a fatty acid and an inhibitor of certain enzymes. Methacetin inhibits the activity of the enzyme acetyl-CoA carboxylase, which catalyzes the conversion of acetyl-CoA to malonyl-CoA, thereby reducing fatty acid synthesis. Methacetin has been shown to be effective in inhibiting the activity of rat liver microsomes at concentrations of 0.01 mM and above. In addition, methacetin has been found to increase the body mass index (BMI) in rats with hepatic impairment and can be used as a biomarker for this condition. Methacetin has been shown to have a molecular docking score of -4.2 kcal/mol when it was docked against human hepatitis B virus (HBV). This indicates that there are strong hydrogen bonding interactions between methacetin and HBV proteins.
Formule :C9H11NO2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :165.19 g/molN-(4-Methoxyphenyl)acetamide
CAS :Formule :C9H11NO2Degré de pureté :98%Couleur et forme :Solid, White to almost white powderMasse moléculaire :165.192






